Santarus, Inc.

Find more results for SNTS


3611 Valley Centre Dr Ste 400
SAN DIEGO, CA 92130-3331
United States - Map
+1-858-3145700 (Phone)
+1-302-6555049 (Fax)

Website links

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing products that address the needs of patients treated by physician specialists. The Company’s products in the United States prescription pharmaceutical market included Uceris (budesonide), Zegerid (omeprazole/sodium bicarbonate), Glumetza (metformin hydrochloride extended release tablets), Cycloset (bromocriptine mesylate) tablets and Fenoglide (fenofibrate) tablets. The Company’s investigational drugs included Ruconest (recombinant human C1 esterase inhibitor), Rifamycin SV MMX, and SAN-300 (anti-VLA-1 antibody).